Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuroscience
Fierce Pharma
Lundbeck relocating US headquarters to Boston in innovation move
From its original U.S. home base in Deerfield, Illinois, Lundbeck now plans to relocate its local headquarters to Greater Boston, Massachusetts.
Fraiser Kansteiner
Sep 25, 2026 10:41am
Lilly pledges up to $237M per program in CNS genetic med collab
Sep 15, 2026 8:42am
Novartis ‘always looking’ for new ways to shuttle drugs to brain
May 28, 2026 8:44am
Tortugas comes out of shell with $106M, 4 ph. 2-stage neuro meds
Apr 21, 2026 10:41am
NIH instability grows with exit of longtime neuro director
Jan 2, 2026 2:16pm
FDA approves 1st nondrug, at-home treatment for depression
Dec 11, 2025 6:00am
